Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Effect of PF-00734200 in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00618007

Public ClinicalTrials.gov record NCT00618007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of 12-Week Administration Of PF-00734200 To Subjects With Type 2 Diabetes Mellitus And Insufficient Glycemic Control On Metformin Treatment

Study identification

NCT ID
NCT00618007
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
289 participants

Conditions and interventions

Interventions

  • PF-00734200 30 mg QD Drug
  • PF-00734200 20 mg QD Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Jun 26, 2011

2008

United States locations

U.S. sites
69
U.S. states
30
U.S. cities
64
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35205
Pfizer Investigational Site Chandler Arizona 85225
Pfizer Investigational Site Litchfield Park Arizona 85340
Pfizer Investigational Site Phoenix Arizona 85051
Pfizer Investigational Site Artesia California 90701
Pfizer Investigational Site Cerritos California 90703
Pfizer Investigational Site Fresno California 93720
Pfizer Investigational Site Greenbrea California 94904
Pfizer Investigational Site Huntington Beach California 92648
Pfizer Investigational Site Los Angeles California 90057
Pfizer Investigational Site National City California 91950
Pfizer Investigational Site Roseville California 95661
Pfizer Investigational Site Valley Village California 91607
Pfizer Investigational Site West Covina California 91790
Pfizer Investigational Site DeFuniak Springs Florida 32435
Pfizer Investigational Site Jacksonville Florida 32205
Pfizer Investigational Site Miami Florida 33143
Pfizer Investigational Site Miami Florida 33169
Pfizer Investigational Site New Port Richey Florida 34652
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Pinecrest Florida 33156
Pfizer Investigational Site St. Petersburg Florida 33702
Pfizer Investigational Site Conyers Georgia 30094
Pfizer Investigational Site Idaho Falls Idaho 83404
Pfizer Investigational Site Indianapolis Indiana 46260
Pfizer Investigational Site Wichita Kansas 67203
Pfizer Investigational Site Lexington Kentucky 40504
Pfizer Investigational Site Madisonville Kentucky 42431
Pfizer Investigational Site Scarborough Maine 04074
Pfizer Investigational Site Baltimore Maryland 21204
Pfizer Investigational Site Oxon Hill Maryland 20745
Pfizer Investigational Site Ann Arbor Michigan 48106
Pfizer Investigational Site Bay City Michigan 48706
Pfizer Investigational Site Canton Michigan 48187
Pfizer Investigational Site Troy Michigan 48098
Pfizer Investigational Site Jackson Mississippi 39209
Pfizer Investigational Site Picayune Mississippi 39466
Pfizer Investigational Site City of Saint Peters Missouri 63376
Pfizer Investigational Site St Louis Missouri 63117
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Las Vegas Nevada 89128
Pfizer Investigational Site Elizabeth New Jersey 07202
Pfizer Investigational Site Trenton New Jersey 08611
Pfizer Investigational Site Albuquerque New Mexico 87106
Pfizer Investigational Site Syracuse New York 13210
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Marion Ohio 43302
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Cumberland Rhode Island 02864
Pfizer Investigational Site Aiken South Carolina 29801
Pfizer Investigational Site Florence South Carolina 29501
Pfizer Investigational Site Kingsport Tennessee 37660
Pfizer Investigational Site Dallas Texas 75230
Pfizer Investigational Site Dallas Texas 75235
Pfizer Investigational Site El Paso Texas 79935
Pfizer Investigational Site Houston Texas 77023
Pfizer Investigational Site Houston Texas 77081
Pfizer Investigational Site Hurst Texas 76054
Pfizer Investigational Site Odessa Texas 79761
Pfizer Investigational Site Pearland Texas 77584
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Salt Lake City Utah 84107
Pfizer Investigational Site Bennington Vermont 05201-5018
Pfizer Investigational Site Ettrick Virginia 23803
Pfizer Investigational Site Richmond Virginia 23225
Pfizer Investigational Site Virginia Beach Virginia 23454
Pfizer Investigational Site Virginia Beach Virginia 23455
Pfizer Investigational Site Spokane Washington 99208
Pfizer Investigational Site Kenosha Wisconsin 53142

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00618007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00618007 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →